DagmarHanaOetteMD

Oncology • Ledgewood, NJ

Physician

Join to view full profile

Are you Dr. Oette?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 38 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
29 Lookout Dr
Ledgewood, NJ 07852
Phone+1 973-927-8957
Is this information wrong?

Summary

Dr. Dagmar Oette, MD is an oncologist in Ledgewood, New Jersey. She is currently licensed to practice medicine in New Jersey.

Education & Training

Temple University HospitalFellowship, Hematology and Medical Oncology, 1981 - 1982
Drexel University College of Medicine/Hahnemann University HospitalFellowship, Hematology and Medical Oncology, 1979 - 1981
Temple University HospitalResidency, Internal Medicine, 1976 - 1979
Lewis Katz School of Medicine at Temple UniversityClass of 1976

Certifications & Licensure

NJ State Medical License 1984 - 2019

Publications & Presentations

PubMed

27 citations
Randomized placebo‐controlled trial of granulocyte‐macrophage colony‐stimulating‐factor support for dose‐intensive cyclophosphamide, etoposide, and cisplatin
Jonathan C. Yau, James A. Neldhart, Pierre L. Triozzi, Shailendra Verma, John Nemunaitis, Donald Quick, David G. Mayernik, Dagmar Oette, Ann F. Hayes, John Holcenberg> ;American Journal of Hematology. 1996 Apr 1
17 citations
Dose escalation trial of cyclophosphamide with Sargramostim in the treatment of central nervous system (CNS) neoplasms.
Daniel H. Lachance, Dagmar Oette, S. Clifford Schold, Mark Brown, Joanne Kurtzberg, Michael L. Graham, Robert D. Tien, Gary J. Felsberg, O. Michael Colvin, Albert Mogh...> ;Medical and Pediatric Oncology. 1995 Apr 1
8 citations
A Phase I Trial of Cyclosphosphamide and Carboplatinum Combined with Interleukin-3 in Women with Advanced-Stage Ovarian Cancer
James L. Speyer, John Mandeli, Howard S. Hochster, Carolyn D. Runowicz, Scott Wadler, Robert C. Wallach, Carmel J. Cohen, Dagmar Oette, Joan Sorich, Erin P. Demakos, L...> ;Gynecologic Oncology. 1995 Mar 1
22 citations
Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in child...
Daniel G. Wright, Richard F. Kenney, Dagmar H. Oette, Vincent F. LaRussa, Laurence A. Boxer, Harry L. Malech> ;Blood. 1994 Aug 15
1 citations
Analysis of radiolabeled CHO cell-derived rHuGM-CSF pharmacokinetics and biodistribution in rhesus monkeys following intravenous and subcutaneous injection.
Scott W. Burchiel, Dagmar Oette, Phillip W. Day, Raymond E. Stoll> ;International Journal of Immunopharmacology. 1994 Feb 1
32 citations
Effects of Interleukin-3 and Granulocyte-Macrophage Colony-Stimulating Factor on Thrombopoiesis in Congenital Amegakaryocytic Thrombocytopenia
Eva C. Guinan, Yi Sheng Lee, Karen Dunn Lopez, Susan Kohler, Dagmar H. Oette, Edward Bruno, Harry P.W. Kozakewich, David G. Nathan, Ronald Hoffman> ;Blood. 1993 Apr 1
37 citations
Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow pr...
Hillard M. Lazarus, Janet Andersen, Michael G. Chen, Diane Variakojis, Edward G. Mansour, Dagmar Oette, Cheryl A. Arce, Martin M. Oken, Stanton L. Gerson> ;Blood. 1991 Aug 1
396 citations
Recombinant Granulocyte-Macrophage Colony-Stimulating Factor after Autologous Bone Marrow Transplantation for Lymphoid Cancer
John Nemunaitis, SN Rabinowe, Jack W. Singer, Philip J. Bierman, Julie M. Vose, Arnold S. Freedman, Nicole Onetto, S Gillis, Dagmar Oette, Morris S. Gold, C. Dean Buck...> ;The New England Journal of Medicine. 1991 Jun 20
56 citations
A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia.
Eva C. Guinan, Colin A. Sieff, Dagmar H. Oette, David G. Nathan> ;Blood. 1990 Sep 15
522 citations
Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression
Karen H. Antman, James D. Griffin, Anthony D. Elias, Mark A. Socinski, Louise Ryan, Stephen A. Cannistra, Dagmar Oette, Mary Whitley, Emil Frei, Lowell E. Schnipper> ;The New England Journal of Medicine. 1988 Sep 8
600 citations
Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Tr...
Stephen J. Brandt, William P. Peters, Susan K. Atwater, Joanne Kurtzberg, Michael J. Borowitz, Roy B. Jones, Elizabeth J. Shpall, Robert C. Bast, Colleen J. Gilbert, D...> ;The New England Journal of Medicine. 1988 Apr 7
489 citations
Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency Syndrome
Jerome E. Groopman, Ronald T. Mitsuyasu, Michael J. DeLeo, Dagmar Oette, David W. Golde> ;The New England Journal of Medicine. 1987 Sep 3
9 citations
Characteristics of the antitrypsin activity of human serum
Peter T. Rowley, Dagmar Oette> ;Journal of Clinical Pathology. 1973 Jan 1
Antiviral activity of the human immunodeficiency virus type 1-specific nonnucleoside reverse transcriptase inhibitor HBY 097 alone and in combination with zidovudine i...
Kleim, J. P., Winters, M., Dunkler, A., Suarez, J. R., Riess, G., Winkler, I., Balzarini, J., Oette, D., Merigan, T. C.> ;J Infect Dis. 1999 Mar
Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial.
Wallis, R. S., Nsubuga, P., Whalen, C., Mugerwa, R. D., Okwera, A., Oette, D., Jackson, J. B., Johnson, J. L., Ellner, J. J.> ;J Infect Dis. 1996 Oct
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous ...
Rowe, J. M., Andersen, J. W., Mazza, J. J., Bennett, J. M., Paietta, E., Hayes, F. A., Oette, D., Cassileth, P. A., Stadtmauer, E. A., Wiernik, P. H.> ;Blood. 1995 Jul 15
Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients.
Baldwin, G. C., Gasson, J. C., Quan, S. G., Fleischmann, J., Weisbart, R., Oette, D., Mitsuyasu, R. T., Golde, D. W.> ;Proc Natl Acad Sci U S A. 1988 Apr
Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factor.
Champlin, R. E., Nimer, S. D., Ireland, P., Oette, D. H., Golde, D. W.> ;Blood. 1989 Feb 15
Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patien...
Pluda, J. M., Yarchoan, R., Smith, P. D., McAtee, N., Shay, L. E., Oette, D., Maha, M., Wahl, S. M., Myers, C. E., Broder, S.> ;Blood. 1990 Aug 1
Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
Champlin, R. E., Nimer, S. D., Oette, D., Golde, D. W.> ;Prog Clin Biol Res. 1990
Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy.
Neidhart, J. A., Mangalik, A., Stidley, C. A., Tebich, S. L., Sarmiento, L. E., Pfile, J. E., Oette, D. H., Oldham, F. B.> ;J Clin Oncol. 1992 Sep
Join now to see all